{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:38:22Z","timestamp":1782603502973,"version":"3.54.5"},"reference-count":4,"publisher":"American Society of Hematology","issue":"7","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2013,2,14]]},"DOI":"10.1182\/blood-2012-11-467787","type":"journal-article","created":{"date-parts":[[2013,2,14]],"date-time":"2013-02-14T20:51:04Z","timestamp":1360875064000},"page":"1238-1239","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":34,"title":["BCR-ABL1 is a secondary event after JAK2V617F in patients with polycythemia vera who develop chronic myeloid leukemia"],"prefix":"10.1182","volume":"121","author":[{"given":"Xiaoli","family":"Wang","sequence":"first","affiliation":[{"name":"Division of Hematology\/Oncology, Tisch Cancer Institute, Myeloproliferative Disorders Research Consortium, Mount Sinai School of Medicine, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Tripodi","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Tisch Cancer Institute, Myeloproliferative Disorders Research Consortium, Mount Sinai School of Medicine, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Kremyanskaya","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Tisch Cancer Institute, Myeloproliferative Disorders Research Consortium, Mount Sinai School of Medicine, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Blouin","sequence":"additional","affiliation":[{"name":"Department of Pathology, Mount Sinai School of Medicine, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Roda","sequence":"additional","affiliation":[{"name":"Geisinger\/Hazleton Cancer Center, Hazleton, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Hoffman","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Tisch Cancer Institute, Myeloproliferative Disorders Research Consortium, Mount Sinai School of Medicine, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vesna","family":"Najfeld","sequence":"additional","affiliation":[{"name":"Department of Pathology and Division of Hematology\/Oncology, Tisch Cancer Institute, Myeloproliferative Disorders Research Consortium, Mount Sinai School of Medicine, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"149","key":"2019111816564997600_B1","doi-asserted-by":"crossref","first-page":"149ra118","DOI":"10.1126\/scitranslmed.3004315","article-title":"Clonal evolution of preleukemic hematopoietic stem cells precedes human acute myeloid leukemia.","volume":"4","author":"Jan","year":"2012","journal-title":"Sci Transl Med"},{"issue":"7381","key":"2019111816564997600_B2","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nature10762","article-title":"Clonal evolution in cancer.","volume":"481","author":"Greaves","year":"2012","journal-title":"Nature"},{"issue":"10","key":"2019111816564997600_B3","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/S1470-2045(07)70295-4","article-title":"Insights into JAK2-V617F mutation in CML.","volume":"8","author":"Bocchia","year":"2007","journal-title":"Lancet Oncol"},{"issue":"7","key":"2019111816564997600_B4","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1038\/sj.leu.2405088","article-title":"JAK2V617F-positive polycythemia vera and Philadelphia chromosome-positive chronic myeloid leukemia: one patient with two distinct myeloproliferative disorders.","volume":"22","author":"Cambier","year":"2008","journal-title":"Leukemia"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/121\/7\/1238\/1367591\/zh800713001238.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/121\/7\/1238\/1367591\/zh800713001238.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T21:57:00Z","timestamp":1574114220000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/121\/7\/1238\/31497\/BCRABL1-is-a-secondary-event-after-JAK2V617F-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,14]]},"references-count":4,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,2,14]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2012-11-467787","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,14]]}}}